期刊文献+

冠心病危险因素分析及颈动脉粥样硬化超声结果的临床意义

暂未订购
导出
摘要 冠状动脉粥样硬化性心脏病(CHD)是严重威胁人类健康的心血管疾病。高频颈动脉超声通过检测动脉内膜中层厚度可以清晰的早期发现动脉粥样硬化,所以颈动脉超声检测可以作为临床预测和筛选CHD的一种较为实用检查方法。
作者 吕艳 柳茵
出处 《青海医药杂志》 2006年第5期62-63,F0004,共3页 Qinghai Medical Journal
  • 相关文献

参考文献15

  • 1沈敏,李兰荪,贾国良,郭文怡,王海昌.超声检测颈动脉粥样硬化及其与冠心病的相关性分析[J].第四军医大学学报,2003,24(6):532-535. 被引量:37
  • 2彭享胜,周澎,曹林生.脂蛋白(a)与冠心病[J].心血管病学进展,2002,23(3):173-176. 被引量:14
  • 3郭士遵.脂代谢异常与动脉粥样硬化状况的关系[J].安徽医科大学学报,2002,37(6):465-467. 被引量:10
  • 4Aronson D, Rayfield EJ, How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol,2002,1 (1) : 1.
  • 5Stration Inl, Adler AI, Neil HA, et al. Association of glycaemia with macrovasculer and microvascular complications of type 2 diabetes prospective observational study. BMJ ,2000,321:405-412.
  • 6刘芳,杨浣宜,张红叶,李建蓉,史秀忠,张技革,康朝辉,杨瑛,芦红艳,姜先雁.超声检测高血压病患者颈动脉粥样硬化的意义[J].中华超声影像学杂志,2003,12(6):381-382. 被引量:36
  • 7Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis . Circulation,2002,105 : 1 135- 1 143.
  • 8Bickel C, Rupprecht H J, Blankenberg S, et al, Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol,2002,89(1) : 12-17.
  • 9Valkonen VP, Pavia H,Salonen JT, et al. Risk of acute coronary events and serum concentrations of asymmetrical dimethylarginine. Laneent, 2001, 358: 2 127-2 128.
  • 10Chiadoni I,Taddi S, Virdis A, et al. Endothelial function and common carotil wall thickening in patients with essential hypertension. Hypertension, 1998,32:25-32.

二级参考文献82

  • 1李宝山,乌日娜,奥.乌力吉,张昕原,刘金,白广林,魏永春,陶春.脂蛋白胆固醇、载脂蛋白B与抗氧化酶脂质过氧化物的关系[J].临床与实验病理学杂志,1996,12(4):334-337. 被引量:5
  • 2[1]Utermann G. The mysteries of lipoprotein(a)[J]. Science, 1989,246: 904-910.
  • 3[2]Mclean JW,Tomlinson JE,Kuang WJ,et al. cDNA sequence of human apolipoprotein (a) is homologus to plasminogen[J]. Nature, 1987,330:132-137.
  • 4[3]Utermann G,Kraft HG,Menzel H,et al. Genetics of quantitative LP(a)lipoprotein trait I. Relation of LP (a) glycoprotein phenotypes to LP (a)lipoprotein concentrations in plasma[J]. Hum Genet, 1988 a, 78:41-46.
  • 5[4]Boerwinkle E. Genetics of plasma LP(a) concentrations[J]. Curr Opin Lipido1,1992,3: 128-134.
  • 6[5]Hofmann SL,Eaton DL,Brann MS,et al. Overexpression of human LDL receptors leads to accelerated catabolism of LP(a) in transgenic mice[J]. J Clin invest, 1990,85 : 1542-1549.
  • 7[6]Rader DJ,Mann WA,Cain W,et al. The LDL receptor is not required for normal catabolism of LP(a) in humans[J]. J Clin Invest,1995,95:1403-1411.
  • 8[7]Ziocheck TF,Powell LM,Rice GC,et al. Interaction of recombinant APO(a)and LP(a) with macrophages[J]. J Clin Invest,1991,87:767-771.
  • 9[8]Albers JJ,Martoving SM. LP(a) quantification:comparison of methods and strategies for standardization[J]. Curr Opin Lipidol, 1994,5 : 417-421.
  • 10[9]Scanu AM,Lawn RM,Berg K. LP(a) and atherocclerosis[J]. Ann Intern Med, 1991,11 5:209-215.

共引文献167

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部